![Cellular Receptors for Viral Entry](https://thenativeantigencompany.com/wp-content/uploads/2019/05/shutterstock_437313772-min.jpg)
![Cellular Receptors for Viral Entry](https://thenativeantigencompany.com/wp-content/uploads/2019/05/shutterstock_437313772-min.jpg)
![The Right Tools for Rubella](https://thenativeantigencompany.com/wp-content/uploads/2019/02/shutterstock_1110401888.jpg)
The Right Tools for Rubella
Rubella remains a significant pathogen worldwide, with 100,000 cases of congenital rubella syndrome estimated to occur every year. Vaccines to Rubella are highly safe and have effectively eliminated endemic infection in many developed countries, yet inadequate...![Native Antigen release a panel of serotype specific monoclonal antibodies](https://thenativeantigencompany.com/wp-content/uploads/2018/08/Dengue-Virus-optimized-1080x675.jpg)